Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
501,650,900
-
Total 13F shares
-
373,748,762
-
Share change
-
+288,041,603
-
Total reported value
-
$11,986,564,928
-
Put/Call ratio
-
154%
-
Price per share
-
$32.07
-
Number of holders
-
339
-
Value change
-
+$9,238,396,533
-
Number of buys
-
307
-
Number of sells
-
31
Institutional Holders of Elanco Animal Health Inc - Common Stock (ELAN) as of Q1 2019
As of 31 Mar 2019,
Elanco Animal Health Inc - Common Stock (ELAN) was held by
339 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
373,748,762 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., MASSACHUSETTS FINANCIAL SERVICES CO /MA/, MORGAN STANLEY, AMUNDI PIONEER ASSET MANAGEMENT INC, LAZARD ASSET MANAGEMENT LLC, and OppenheimerFunds, Inc..
This page lists
342
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.